See more : Redcare Pharmacy NV (SHPPF) Income Statement Analysis – Financial Results
Complete financial analysis of Artemis Medicare Services Limited (ARTEMISMED.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Artemis Medicare Services Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Holders Technology plc (HDT.L) Income Statement Analysis – Financial Results
- Capstone Therapeutics Corp. (CAPS) Income Statement Analysis – Financial Results
- Henkel AG & Co. KGaA (HEN3.SW) Income Statement Analysis – Financial Results
- Propanc Biopharma, Inc. (PPCB) Income Statement Analysis – Financial Results
- Gujarat Gas Limited (GUJGAS.BO) Income Statement Analysis – Financial Results
Artemis Medicare Services Limited (ARTEMISMED.NS)
About Artemis Medicare Services Limited
Artemis Medicare Services Limited manages and operates multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a 541 bed multi-specialty hospital located in Gurugram, India. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.79B | 7.37B | 5.53B | 4.08B | 5.57B | 5.37B | 5.03B | 4.63B | 4.02B | 3.68B |
| Cost of Revenue | 7.01B | 6.33B | 4.57B | 3.70B | 4.96B | 4.73B | 4.33B | 3.94B | 1.84B | 1.56B |
| Gross Profit | 1.78B | 1.04B | 954.40M | 371.67M | 617.20M | 646.49M | 702.19M | 697.33M | 2.18B | 2.12B |
| Gross Profit Ratio | 20.21% | 14.07% | 17.27% | 9.12% | 11.08% | 12.03% | 13.97% | 15.05% | 54.13% | 57.68% |
| Research & Development | 85.76M | 36.42M | 32.07M | 33.10M | 19.11M | 44.06M | 5.82M | 1.40M | 0.00 | 0.00 |
| General & Administrative | 42.12M | 36.82M | 36.53M | 26.50M | 20.32M | 36.80M | 63.97M | 86.92M | 82.40M | 0.00 |
| Selling & Marketing | 43.10M | 69.48M | 23.68M | 9.68M | 33.19M | 35.54M | 34.82M | 31.83M | 24.77M | 0.00 |
| SG&A | 85.22M | 334.82M | 451.82M | 185.48M | 256.50M | 254.60M | 272.62M | 295.17M | 241.68K | 74.36M |
| Other Expenses | 0.00 | -17.50M | -16.89M | -8.70M | -10.73M | -5.17M | -6.19M | -3.94M | -1.90M | 0.00 |
| Operating Expenses | 170.98M | 388.74M | 500.78M | 227.28M | 286.35M | 259.77M | 284.63M | 300.51M | 2.14M | 1.82B |
| Cost & Expenses | 7.18B | 6.72B | 5.07B | 3.93B | 5.24B | 4.99B | 4.61B | 4.24B | 2.14M | 3.37B |
| Interest Income | 0.00 | 29.76M | 14.89M | 18.24M | 5.01M | 13.58M | 59.56M | 59.65M | 47.24M | 93.68M |
| Interest Expense | 312.87M | 196.77M | 119.75M | 129.25M | 127.98M | 109.97M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 311.39M | 310.04M | 221.93M | 215.14M | 226.31M | 200.74M | 188.06M | 154.93M | 120.64M | 121.55M |
| EBITDA | 1.25B | 1.01B | 713.53M | 359.53M | 660.58M | 678.16M | 631.30M | 574.83M | -2.14M | 437.76M |
| EBITDA Ratio | 14.18% | 13.00% | 12.22% | 8.82% | 10.00% | 10.94% | 12.05% | 11.91% | -0.05% | 11.91% |
| Operating Income | 1.60B | 647.75M | 453.62M | 144.39M | 330.86M | 386.72M | 417.56M | 396.81M | -2.14M | 316.22M |
| Operating Income Ratio | 18.27% | 8.79% | 8.21% | 3.54% | 5.94% | 7.20% | 8.30% | 8.56% | -0.05% | 8.60% |
| Total Other Income/Expenses | -920.21M | -694.33M | -81.77M | -69.09M | -24.57M | -19.27M | -68.51M | -71.21M | 3.58M | 210.85M |
| Income Before Tax | 684.53M | 506.06M | 371.85M | 75.30M | 306.29M | 367.45M | 349.04M | 325.60M | 1.43M | 210.79M |
| Income Before Tax Ratio | 7.79% | 6.87% | 6.73% | 1.85% | 5.50% | 6.84% | 6.94% | 7.03% | 0.04% | 5.74% |
| Income Tax Expense | 193.08M | 125.95M | 57.83M | 13.70M | 111.69M | 163.56M | 86.28M | 54.45M | 703.62K | 25.01M |
| Net Income | 491.41M | 385.98M | 318.14M | 64.86M | 197.93M | 204.93M | 262.76M | 271.15M | 728.67K | 185.78M |
| Net Income Ratio | 5.59% | 5.24% | 5.76% | 1.59% | 3.55% | 3.81% | 5.23% | 5.85% | 0.02% | 5.06% |
| EPS | 3.62 | 2.89 | 2.40 | 0.49 | 1.50 | 0.31 | 0.40 | 0.41 | 0.15 | 0.88 |
| EPS Diluted | 3.53 | 2.79 | 2.29 | 0.49 | 1.50 | 0.31 | 0.40 | 0.41 | 0.15 | 0.88 |
| Weighted Avg Shares Out | 135.77M | 133.36M | 132.38M | 132.38M | 132.38M | 661.89M | 661.89M | 661.89M | 5.00M | 210.40M |
| Weighted Avg Shares Out (Dil) | 139.25M | 138.59M | 139.02M | 132.38M | 132.38M | 661.89M | 661.89M | 661.89M | 5.00M | 210.35M |
Source: https://incomestatements.info
Category: Stock Reports